Scientists Develop AI-Discovered Antibiotic That Targets Crohn's Disease Bacteria While Preserving Healthy Gut Microbes
MIT and McMaster University researchers use AI to discover enterololin, a revolutionary narrow-spectrum antibiotic that targets harmful gut bacteria causing Crohn's disease while preserving beneficial microbes, showing promising results in mouse studies and advancing toward human trials.